Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Kingsley Hampton"'
Autor:
Huyen Tran, Sylvia von Mackensen, Aby Abraham, Giancarlo Castaman, Kingsley Hampton, Paul Knoebl, Silvia Linari, Jan Odgaard-Jensen, Jesper Skov Neergaard, Oleksandra Stasyshyn, Jay Jay Thaung Zaw, Bulent Zulfikar, Amy Shapiro
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 4, Pp 102476- (2024)
Background: Patient-reported outcomes (PROs) reflect patient perceptions of disease and treatment and are important for evaluating new therapies. Objectives: Evaluate the effects of once-daily concizumab prophylaxis on health-related quality of life
Externí odkaz:
https://doaj.org/article/54456b8b4b324d3d9fb628b1338a8141
Publikováno v:
Patient preference and adherence
Patient preference and adherence, Auckland : Dove Medical Press Ltd, 2021, vol. 15, p. 2443-2454
Patient Preference and Adherence, Vol Volume 15, Pp 2443-2454 (2021)
Patient preference and adherence, Auckland : Dove Medical Press Ltd, 2021, vol. 15, p. 2443-2454
Patient Preference and Adherence, Vol Volume 15, Pp 2443-2454 (2021)
Purpose To illustrate the benefits of the extended half-life (EHL) recombinant factor VIII product N8-GP (Esperoct®, turoctocog alfa pegol) by describing individual cases of patients with severe hemophilia A treated with N8-GP in the pathfinder clin
Autor:
Kingsley Hampton, Paul Knoebl, Jan Odgaard-Jensen, Oleksandra Stasyshyn, Jay Jay Thaung Zaw, Jesper Skov Neergaard, Bulent Zulfikar
Publikováno v:
Blood. 140:5591-5592
Autor:
Sameer Mistry, Stephen S. Johnston, Gaurav Gangoli, W. Danker, Simran Jain, Nadine Jamous, Kingsley Hampton, Eric M. Ammann
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Stephen S Johnston,1 Nadine Jamous,2 Sameer Mistry,3 Simran Jain,4 Gaurav Gangoli,5 Walter Danker,5 Eric Ammann,6 Kingsley Hampton7 1Department of Epidemiology, Medical Devices, Johnson & Johnson, New Brunswick, NJ, USA; 2Department of Health Economi
Autor:
Kingsley Hampton, Steven R. Lentz, Chunduo Shen, Elena Santagostino, Karina Meijer, Anne T. Neff, Jameela Sathar, Alberto Tosetto, Andrea Landorph, László Nemes, Pratima Chowdary
Publikováno v:
Haemophilia, 26(3), 450-458. Wiley
Haemophilia
Haemophilia
Introduction Turoctocog alfa pegol is a glycoPEGylated recombinant factor VIII (FVIII) with an extended half‐life developed for prophylaxis, treatment of bleeds and perioperative management in patients with haemophilia A. Aim Evaluate the efficacy
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(1)
INTRODUCTION Joint damage in haemophilia often requires surgical correction. However, the surgery effect on bleeding rates and other clinical joint outcomes can be unclear. AIM To investigate the effects of joint surgery on joint annualized bleeding
Autor:
Víctor Jiménez-Yuste, Andreas Tiede, Kingsley Hampton, Soraya Benchikh El Fegoun, Guy Young, Pratima Chowdary
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(1)
Introduction Challenges with personalised prophylaxis in haemophilia remain, including designing unique dosing schedules that require continual adjustments and monitoring using complex sampling procedures. Aim To assess long-term efficacy and pharmac
Publikováno v:
2019 Computing in Cardiology Conference (CinC).
Autor:
Kingsley Hampton, Pratima Chowdary, Lotte Jacobsen, Elena Santagostino, Hideyuki Takedani, Silke Ehrenforth, Jameela Sathar, Clifford M. Takemoto, Claude Negrier, Scott Dunkley, Anne T. Neff
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 23(5)
Background N8-GP (turoctocog alfa pegol) is an extended half-life glycoPEGylated recombinant factor VIII (FVIII) product developed for the prevention and treatment of bleeds in haemophilia A patients. Aim This is a planned interim analysis of pathfin
Publikováno v:
Medical Teacher. 28:535-543
In the UK, and in many Commonwealth countries, a university degree is accepted by registration bodies as an indication of competence to practice as a PRHO or intern. Concerns have been raised that the quality of university examinations may not always